Dr. Jose Carlos Gutiérrez Ramos is an Independent Director at Bicycle Therapeutics Plc, a Chief Science Officer & Senior Vice President at Danaher Corp., a President & Chief Executive Officer at Cogen Immune Medicine, Inc. and a Chief Executive Officer at Excaliard Pharmaceuticals, Inc. He is on the Board of Directors at Bicycle Therapeutics Plc. Dr. Gutiérrez Ramos was previously employed as a Vice President-Drug Discovery by AbbVie, Inc., a President, Chief Executive Officer & Director by Repertoire Immune Medicines, Inc., an Independent Director by Oryzon Genomics SA, an Independent Director by Momenta Pharmaceuticals, Inc., a President & Chief Executive Officer by Synlogic Operating Co., Inc., a President, Chief Executive Officer & Director by Synlogic, Inc., a SVP-Research & Development by Pfizer Inc., a Senior Vice President by Avidia, Inc., a Chief Scientific Officer by Peptimmune, Inc., a Member by Basel Institute for Immunology, a SVP, Head-BioTherapeutics Research & Development by Centers for Therapeutic Innovation, a Chief Scientific Officer by Genetrix, Inc., a Senior Vice President by GlaxoSmithKline AG, an Assistant Professor by Harvard University, a Vice President-Inflammation by Millennium Pharmaceuticals, Inc., and a Professor by National Center for Biotechnology Information. He also served on the board at Evelo Biosciences, Inc. He received his undergraduate degree from Universidad Complutense de Madrid and a doctorate degree from Universidad Autónoma de Madrid.